NCT02791373View on ClinicalTrials.gov

Vinorelbine and Gemcitabine in Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Multiple MyelomaAmyloidosis
Interventions
DRUG

Vinorelbine

Mobilisation Chemotherapy

DRUG

Gemcitabine

Mobilisation Chemotherapy

Trial Locations (1)

3010

Department for Medical Oncology; University Hospital/Inselspital, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT02791373 - Vinorelbine and Gemcitabine in Myeloma | Biotech Hunter | Biotech Hunter